Editorial
doi: 10.1213/01.ANE.0000228302.15293.DE.
Pediatric drug development in anesthesiology: an FDA perspective
- PMID: 16790624
- DOI: 10.1213/01.ANE.0000228302.15293.DE
Item in Clipboard
Editorial
Pediatric drug development in anesthesiology: an FDA perspective
Anesth Analg.
2006 Jul.
No abstract available
Comment on
-
Pediatric research and scholarship: another Gordian knot?Anesth Analg. 2006 Jul;103(1):43-8. doi: 10.1213/01.ANE.0000220033.34889.CE. Anesth Analg. 2006. PMID: 16790623 No abstract available.
Similar articles
-
FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.Food Drug Law J. 2009;64(1):183-223. Food Drug Law J. 2009. PMID: 19998746
-
Charging for investigational drugs under an investigational new drug application. Final rule.Fed Regist. 2009 Aug 13;74(155):40871-900. Fed Regist. 2009. PMID: 19691172
-
Communicating with the FDA: the "third rail" of a new model for drug development.J Clin Pharmacol. 2008 Feb;48(2):144-5. doi: 10.1177/0091270007313560. J Clin Pharmacol. 2008. PMID: 18199890 No abstract available.
-
Innovative early development regulatory approaches: expIND, expCTA, microdosing.Clin Pharmacol Ther. 2008 Feb;83(2):358-60. doi: 10.1038/sj.clpt.6100461. Epub 2007 Dec 19. Clin Pharmacol Ther. 2008. PMID: 18091759 Review.
-
Pediatric clinical trial experience: government, child, parent and physician's perspective.Pediatr Infect Dis J. 2003 Dec;22(12):1124-7. doi: 10.1097/01.inf.0000101847.22501.e7. Pediatr Infect Dis J. 2003. PMID: 14688585 Review.
Cited by
-
Drug selection for sedation and general anesthesia in children undergoing ambulatory magnetic resonance imaging.Yeungnam Univ J Med. 2020 Jul;37(3):159-168. doi: 10.12701/yujm.2020.00171. Epub 2020 Apr 17. Yeungnam Univ J Med. 2020. PMID: 32299181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
